Dr. Mark E. Burnett, MD

Dr. Burnett practices at California Dermatology Group in Santa Barbara, California.

Dr. Burnett's NPI, 1104182393, was assigned on April 2, 2012. Dr. Burnett graduated from Icahn School Of Medicine At Mount Sinai in 2012. Dr. Burnett holds California license 150033.

Dr. Burnett's primary practice is California Dermatology Group, at 2323 Oak Park Ln, Santa Barbara, CA 93105 in Santa Barbara County. The practice phone is (805) 892-8111.

Dr. Burnett's primary practice is California Dermatology Group in Santa Barbara, California. The medical group on file is California Dermatology Group. Dmand AI also links Dr. Burnett to 1 more group practice or clinic, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Burnett practices, 2 sites in all. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Dr. Burnett's primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dr. Burnett is board certified in acls by the Advanced Cardiac Life Support. Dmand AI has Dr. Burnett's licenses on file in 3 states: California, Pennsylvania and New York.

CMS data shows 17,263 Medicare services from Dr. Burnett across 62 procedure codes in 2024, for 1,800 Medicare patients. Medicare paid $1,835,840 for them. Every service was in an office.

CMS counts 1,800 Medicare patients who saw Dr. Burnett in 2024. The largest group is 65 to 74, with 840 patients. 73% of them have high cholesterol, and 57% have high blood pressure. 7% are also on Medicaid. Their average risk score is 0.99, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Burnett's median patient age at 70, with 52% women.

In 2024, Dr. Burnett wrote 450 Medicare Part D claims for 253 patients. 98% of them were for generic drugs. CMS names the drug for 360 of them, across 10 drugs with 11 or more claims each, at $4,998 in total drug cost. In 2023, CMS named 270 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Burnett for performance year 2024, reported as part of a group. Dr. Burnett accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 5,395 procedures of removal of skin lesions by Dr. Burnett, more than 99% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 13 papers to Dr. Burnett, published from 2008 to 2020. 2008 was the busiest year, with 2. The most frequent topics are Skin Neoplasms, Sunscreening Agents and Ultraviolet Rays. Dr. Burnett has published most often in J Am Acad Dermatol. Dr. Burnett's most frequent co-authors are Rebecca Marie Jansen, MD, Sebastian Gordon Bernardo, MD and David G. Brodland, MD.

CMS Open Payments shows 61 general payments to Dr. Burnett from 15 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 94% of the total. Amgen Inc. paid the most, $193.

Dmand AI lists 12 awards for Dr. Burnett, most recently Distinguished Housestaff Award in 2015.

Dr. Burnett graduated from Icahn School Of Medicine At Mount Sinai in 2012. Dr. Burnett is a member of AOA and AAD.

Dr. Burnett is in network with 17 carriers, including Aetna, Elevance and Highmark. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.